Deep-tech company Gennate Ltd has received £550,000 of seed funding to help it develop nanomaterial plant nutrition technology.
The funding will help with the commercialisation of UK-developed scientific innovation, helping the company transition from laboratory development to pilot-scale manufacturing.
Gennate has developed a novel continuous-flow nanoreactor platform that enables the low-cost, scalable production of nano-sized macro- and micronutrients. The technology addresses long-standing manufacturing and cost barriers that have limited the global adoption of nanofertilisers, while supporting more efficient nutrient delivery and reduced environmental losses. Gennate’s nanofertiliser formulations have already shown 30% increase in wheat seed germination and >50% yield increases in growth and biomass of crops.
Gennate founder and CEO Dr Imad Naasani says: “This funding is a strong validation of our scientific breakthrough and our vision to make nanotechnology commercially viable at an industrial scale. It enables us to move decisively toward pilot production and sets the company up for early product deployment and global growth.”
